European Journal of Cancer
Volume 41, Issue 14 , Pages 2079-2085 , September 2005

Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution

  • Gaetano Bacci

      Affiliations

    • Chemotherapy, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 051 6366 829; fax: +39 051 6366 277.
    • ,
  • Mario Mercuri

      Affiliations

    • Orthopaedic Surgery, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • ,
  • Alessandra Longhi

      Affiliations

    • Chemotherapy, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • ,
  • Stefano Ferrari

      Affiliations

    • Chemotherapy, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • ,
  • Franco Bertoni

      Affiliations

    • Pathology, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • ,
  • Michela Versari

      Affiliations

    • Chemotherapy, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy
    • ,
  • Piero Picci

      Affiliations

    • Oncologic Research, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy

Received 17 December 2004 ,Revised 31 March 2005 ,Accepted 31 March 2005.

References 

  1. Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49:1221–1230
  2. Winkler K, Beron G, Kotz R, et al. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a cooperative German/Austrian study. J Clin Oncol. 1984;2:617–624
  3. Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol. 1988;6:329–337
  4. Bacci G, Picci P, Ferrari S, et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremity. Cancer. 1993;72:3227–3238
  5. Saeter G, Alvegard TA, Elomaa I, et al. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study. J Clin Oncol. 1991;9:1766–1775
  6. Kalifa C, Razafindrakoto H, Vassal G, et al. Chemotherapy in osteogenic sarcoma: the experience of the pediatric department of the Goustave Roussy Institute. Cancer Treat Res. 1993;62:347–349
  7. Benjamin RS, Chawla SP, Carrasco CH, et al. Preoperative chemotherapy for osteosarcoma with intravenous doxorubicin and intra-arterial cis-platinum. Ann Oncol. 1992;2:3–6
  8. Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children’s Cancer Group. J Clin Oncol. 1997;15:76–84
  9. Wunder JS, Paulian G, Huvos AG, et al. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am. 1998;80:1020–1033
  10. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocol. J Clin Oncol. 1991;9:1766–1775
  11. Huvos AG, Rosen G, Marcove RC, et al. Pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med. 1977;101:14–18
  12. Salzer-Kuntschik M, Brand G, Delling G, et al. Bestimmung des morphologischen regressionsgrade nach chemotherapie bei malignen knochetumoren. Pathologe. 1983;4:135–141
  13. Ayala AG, Raymond KR, Jaffe N, et al. The pathologist’s role in diagnosis and treatment of osteosarcoma in children: controversies, current status and projections. Hum Pathol. 1984;15:258–266
  14. Bacci G, Picci P, Ruggieri P, et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Ortopedico Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer. 1990;65:2539–2553
  15. Goorin AM, Schwartzentruber DJ, Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003;21:1574–1580
  16. Enneking WF, Spanier S, Goodman MA, et al. A system for the surgical staging of musculoskeletal sarcomas. Clin Orthop. 1980;153:106–120
  17. Picci P, Bacci G, Campanacci M, et al. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Cancer. 1985;56:1515–1521
  18. Bacci G, Ferrari S, Mercuri M, et al. Neoadjuvant chemotherapy for extremity osteosarcoma. Preliminary results of the Rizzoli’s 4th Study. Acta Oncol. 1998;37:41–48
  19. Ferrari S, Mercuri M, Picci P, et al. Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response. Tumori. 1999;85:458–464
  20. Bacci G, Ferrari S, Longhi A, et al. High-dose ifosfamide in combination with high-dose methotrexate, doxorubicin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study. J Chemother. 2002;14:198–206
  21. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at Istituto Ortopedico Rizzoli accordino to the IOR/OS-2 protocol: an updated report. J Clin Oncol. 2000;18:4016–4027

PII: S0959-8049(05)00558-7

doi: 10.1016/j.ejca.2005.03.036

European Journal of Cancer
Volume 41, Issue 14 , Pages 2079-2085 , September 2005

Article Tools